MARVAX
Dead / Abandoned — Abandoned — failure to respond (as of 09 Sept 2025)
What this means for you
This application is over — abandoned 04 Aug 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97645573
- Mark type
- Stylized text
- Filed
- 24 Oct 2022
- Abandoned
- 04 Aug 2025
- Attorney of record
- KARI MOYER-HENRY
Goods and services
- Class 005 — Pharmaceuticals: Vaccine preparations, namely, vaccines for immunization of humans against Marburg Virus Disease
Owner
- Soligenix, Inc., Princeton, NJ, US
Prosecution history
- 10 Sept 2025 — EXPARTE APPEAL TERMINATED
- 09 Sept 2025 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 09 Sept 2025 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 24 Apr 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 24 Apr 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 01 Feb 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 01 Feb 2025 — NON-FINAL ACTION E-MAILED
- 01 Feb 2025 — NON-FINAL ACTION WRITTEN
- 27 Jan 2025 — AMENDMENT TO USE PROCESSING COMPLETE
- 27 Jan 2025 — USE AMENDMENT FILED
- 27 Jan 2025 — TEAS AMENDMENT OF USE RECEIVED
- 27 Jan 2025 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 27 Jan 2025 — EX PARTE APPEAL-INSTITUTED
- 27 Jan 2025 — JURISDICTION RESTORED TO EXAMINING ATTORNEY
- 27 Jan 2025 — EXPARTE APPEAL RECEIVED AT TTAB